Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0314 | 1 | 1 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0314 | 1 | 1 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0314 | 1 | 1 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0035 | 0.0177 | 0.0177 |
Echinococcus multilocularis | eukaryotic initiation factor 4A III | 0.0314 | 1 | 1 |
Echinococcus granulosus | eukaryotic initiation factor 4A | 0.0314 | 1 | 1 |
Trypanosoma brucei | Eukaryotic initiation factor 4A-1 | 0.0314 | 1 | 0.5 |
Brugia malayi | Inhibitor of Apoptosis domain containing protein | 0.0162 | 0.4649 | 0.4552 |
Plasmodium falciparum | eukaryotic initiation factor 4A | 0.0314 | 1 | 1 |
Echinococcus granulosus | baculoviral IAP repeat containing protein | 0.0162 | 0.4649 | 0.4649 |
Echinococcus multilocularis | eukaryotic initiation factor 4A | 0.0314 | 1 | 1 |
Giardia lamblia | Translation initiation factor eIF-4A, putative | 0.0314 | 1 | 0.5 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0314 | 1 | 0.5 |
Onchocerca volvulus | Eukaryotic initiation factor 4A homolog | 0.0314 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0162 | 0.4649 | 0.4649 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0314 | 1 | 0.5 |
Toxoplasma gondii | eukaryotic initiation factor-4A, putative | 0.0314 | 1 | 1 |
Onchocerca volvulus | 0.0162 | 0.4649 | 0.4552 | |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0033 | 0.0114 | 0.0114 |
Schistosoma mansoni | inhibitor of apoptosis protein | 0.0162 | 0.4649 | 0.4649 |
Echinococcus granulosus | inhibitor of apoptosis protein | 0.0162 | 0.4649 | 0.4649 |
Loa Loa (eye worm) | hypothetical protein | 0.0162 | 0.4649 | 0.4552 |
Echinococcus granulosus | eukaryotic initiation factor 4A III | 0.0314 | 1 | 1 |
Onchocerca volvulus | Deterin homolog | 0.0162 | 0.4649 | 0.4552 |
Plasmodium vivax | RNA helicase-1, putative | 0.0314 | 1 | 1 |
Schistosoma mansoni | inhibitor of apoptosis (iap) domain family member | 0.0162 | 0.4649 | 0.4649 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0314 | 1 | 0.5 |
Echinococcus multilocularis | baculoviral IAP repeat containing protein | 0.0162 | 0.4649 | 0.4649 |
Mycobacterium tuberculosis | Probable cold-shock DeaD-box protein A homolog DeaD (ATP-dependent RNA helicase dead homolog) | 0.0314 | 1 | 0.5 |
Brugia malayi | Inhibitor of Apoptosis domain containing protein | 0.0162 | 0.4649 | 0.4552 |
Entamoeba histolytica | DEAD/DEAH box helicase, putative | 0.0314 | 1 | 0.5 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0314 | 1 | 1 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0314 | 1 | 1 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0314 | 1 | 1 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0314 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0162 | 0.4649 | 0.4552 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.0177 | 0.0177 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0035 | 0.0177 | 0.0177 |
Echinococcus multilocularis | inhibitor of apoptosis protein | 0.0162 | 0.4649 | 0.4649 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0033 | 0.0114 | 0.0114 |
Treponema pallidum | ATP-dependent RNA helicase | 0.0314 | 1 | 0.5 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 3 | 0.0033 | 0.0114 | 0.0114 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Log SP (functional) | S 0 | Sweet potency as logarithm of sweet potency (log SP) relative to sucrose; Sweet | ChEMBL. | 7241515 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.